SEC Form 4 · accession 0000897069-26-001478
Processa Pharmaceuticals, Inc. · PCSA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Russell Skibsted
Officer — Chief Financial Officer
Period of report
Jun 30, 2026
Accepted (ET)
Jul 1, 2026 · 4:17 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001533743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 30, 2026 | P | 3,277 | $1.93 | A | 16,689 | D |
Table II — derivative securities
No Table II lines on this filing.